• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
IMCS

IMCS

A leader in recombinant enzymes and automated micro-chromatography technologies

  • ABOUT
    • ABOUT IMCS
    • QUALITY POLICY
    • RESEARCH AT IMCS
    • CAREERS
  • PRODUCTS
    • IMCSzyme®
      • IMCSzyme E1F
      • IMCSzyme RT
      • IMCSzyme® CATALOG
    • IMCStips®
      • APPLICATIONS
        • AFFINITY
        • SIZE EXCLUSION
        • NUCLEIC ACIDS
        • ION EXCHANGE
        • REVERSE PHASE
        • PHOSPHOPEPTIDE
      • IMCStips® CATALOG
      • AUTOMATION PLATFORMS
        • DYNAMIC DEVICES
        • HAMILTON
        • INTEGRA
        • TECAN
        • OPENTRONS
        • ANALYTIK JENA
    • SULFATASES
      • Sulfazyme
      • Sulfazyme™ DS
      • Sulfazyme™ β-AS
    • GLYCO REAGENTS
      • GLYCOLIPIDS
      • ACTIVATED SUGARS
      • BIOSYNTHETIC ENZYMES
      • SMALL MOLECULES
    • SPHINGOSINES
    • OTHER PROTEINS
      • PURIFIED STREPTAVIDIN
      • B. pi. β-glucuronidase variant
  • SERVICES
    • BETA-GLUCURONIDASES & SULFATASES
      • β-GLUCURONIDASE VALIDATION SERVICES
      • HIGH-THROUGHPUT TOXICOLOGY WORKFLOWS
    • IMCStips®
      • SAMPLE PREPARATION AUTOMATION
      • HIGH-THROUGHPUT METHOD DEVELOPMENT
      • AUTOMATION PLATFORMS
        • DYNAMIC DEVICES
        • HAMILTON
        • INTEGRA
        • TECAN
        • OPENTRONS
        • ANALYTIK JENA
    • OTHER SERVICES
      • GLYCAN PRODUCTION (Coming Soon)
      • R&D COLLABORATIONS
      • EXTRACELLULAR VESICLES
  • RESOURCES
    • FAQ
    • IMCSZYME RESOURCES
    • IMCSTIPS RESOURCES
    • SAFETY DATA SHEETS
    • CERTIFICATE OF ANALYSIS
  • LATEST NEWS
    • LATEST NEWS
    • PODCAST
    • BLOG
    • EVENTS
    • WEBINARS
  • SHOP
  • CONTACT
  • en
    • en
    • es
    • fr
    • de
    • zh-CN
Image of blue rendered molecular structure

IMCS at SLAS 2024

IMCS Poster Presentation Downloads

PO_SLAS_2024_Automated_Plasmid-Purification_Protocol_Hamilton_V1_Thumb

(1216-A) An automated plasmid purification protocol – avoiding ancillary equipment and reducing manual intervention

Abstract Expand

Abstract: Adoption of automated liquid handler workflows has become a primary means to address the ever-increasing demand for the new biotherapeutics. Plasmid purification remains a critical step in the development of novel therapeutics, initial product development, and enzyme engineering. A traditional approach for plasmid purification is to use silica columns in either an individual spin column format or in a 96-well plate. These approaches work well, but require frequent manual intervention, and sufficient centrifuge space. Throughput is limited by time, centrifuge space, and balance requirements. In this work, a pipette-based dispersive solid phase extraction (dSPE) is utilized to purify plasmid DNA. While this functionality exists on automated liquid handlers in the form of packed column beds, magnetic bead purifications, and positive-pressure manifold plates, the workflow presented herein requires no additional off-deck steps, is fully automated, and provides comparable yields and quality. By using a loosely packed resin, we aimed to avoid the pitfalls of other automated methods such as channeling (packed beds and positive pressure manifolds), difficult liquid handling and resultant poor washing (magnetic beads), and on-deck manipulations such as plate movement, centrifugation, and shaking (all methods).

We systematically purified pDNA from bacterial lysates containing plasmids of different sizes (3262 – 8484 bps) using our automated method employing loosely-packed silica tips. The effectiveness of our method was benchmarked against commercially available spin plates and magnetic bead kits. Our method demonstrated higher overall recoveries when compared to magbeads and comparable yields when compared to the manual spin plate, yielding pDNA amounts between 8.92±0.62 µg and 12.28±0.24 µg. Moreover, the resulting purity compared well to alternative methods, with 260/280 and 260/230 ratios of 1.85 and 2.03 across all samples.

Overall, yields and purity were comparable to the spin-plate method. Time from sample isolation to purification was under one hour for up to 96 samples, comparable to the spin-plate method and faster than the magbead workflow (75 minutes). This work represents an adaptation of a traditional plasmid purification workflow for automated liquid handlers. Challenges such as carryover and buffer selection when the purification is automated in pipette tips are identified and how these challenges were overcome are discussed. The workflow can process 96 samples quickly (<60 minutes), while maintaining high yields (>10 µg) and excellent purity.

Download PDF
PO_SLAS_2024_Automated_Size_Exclusion_Workflows_Dynamic_Devices_V1_Thumb

(1038-C) Fully automated size exclusion chromatography workflows for biomolecules with Dynamic Devices Lynx, for sample volumes of 100 µL up to 1 mL

Abstract Expand

Abstract: Size exclusion chromatography (SEC) is vital in biotechnology for separating molecules by size, aiding sample prep through buffer exchange for downstream compatibility, and removing interfering contaminants like salts for subsequent analyses. SEC methods can be manual, using resin-containing spin columns or cartridges, or automated with pre-packed filter plates (96-well plates with resin) loaded by a liquid handler. While both approaches are effective, they have limitations. Automated systems offer a rapid and less labor-intensive option; however, they are more restrictive in terms of sample size and require an off-deck centrifugation step that prevents further integration with other workflows. To address these limitations, IMCS has developed SizeX—a miniaturized SEC column incorporated into a larger pipette tip to accommodate larger sample volumes of up to 1 mL. This new design allows users to load samples via the top of the tips onto a packed resin bed and subsequently push the solution through the resin bed using positive pressure generated by the liquid handler's plunger. By utilizing the pipette tip as a chromatography column, SizeX eliminates the need for centrifuges associated with traditional SEC methods. The objective was to develop an automated, high-throughput SEC workflow with the Dynamic Devices Lynx liquid handling system. This method accommodates sample volumes ranging from 100 µL to 1 mL, making it suitable for a wide range of applications. This workflow consists of a few key steps, including a blowout step to remove the storage buffer, an equilibration step to prepare the resin, sample loading with a dispense step to settle the sample into the resin bed, and a chaser step involving elution buffer loading and a dispense step that yields the final product. Method testing focused on recovering green fluorescent protein (GFP) and IgG at varying concentrations, ranging from 0.1 mg/mL to 1.0 mg/mL, and measuring desalting efficiency using bromophenol blue (BPB) and tartrazine solutions. The average GFP recovery for SizeX100 was 84% ± 3%, and for SizeX1000, 85% ± 4%; for sample sizes of 100 µL and 1 mL, respectively; IgG recoveries were comparable to GFP. Moreover, our desalting experiments showcased salt removal of 98% ± 0.5% and ≥99% for 100 µL and 1 mL samples respectively. Results demonstrated that SizeX enables fully automated, rapid buffer exchange and desalting of purified proteins without using centrifuges or other equipment beyond the liquid handler.

Download PDF

For more related content please see our Resources Page.

Sidebar

"*" indicates required fields

Name*
Email me a copy
Consent

Customize Your Workflow

IMCS recognizes our customers’ needs vary, which is why we provide tailored tools and services to help you reach your laboratory’s goals.

VIEW OUR CUSTOM SOLUTIONS

ABOUT IMCS

INTEGRATED MICRO-CHROMATOGRAPHY SYSTEMS, INC. (IMCS) IS A BIOTECHNOLOGY COMPANY FOCUSED ON DELIVERING TOOLS AND SERVICES THAT HELP PAVE THE WAY FOR THE FUTURE OF PRECISION MEDICINE. WE STRIVE TO ADDRESS THE GROWING NEEDS OF CLINICAL AND RESEARCH LABORATORIES THROUGH ADVANCED TECHNOLOGIES THAT INCREASE TESTING EFFICIENCY AND ACCURACY.

STAY UP TO DATE

WANT REGULAR UPDATES ON OUR INNOVATIVE PRODUCTS?
Sign up to receive exclusive emails and offers from IMCS.
!
!
!
Subscribe
Something went wrong. Please check your entries and try again.

ABOUT

ABOUT IMCS

CAREERS

QUALITY POLICY

RESEARCH AT IMCS

PRODUCTS

IMCSZYME

IMCSZYME RT

IMCSTIPS

PROTEINS, ENZYMES, RESINS

GLYCO REAGENTS

TERMS

TERMS OF USE

PRIVACY POLICY

STANDARD TERMS AND CONDITIONS

FCOI POLICY

CONNECT WITH US

IMCS, Inc. Headquarters
110 Centrum Drive
Irmo, SC 29063

  • IMCS LinkedIn Page
  • IMCS Facebook Page
  • IMCS Twitter Page

COPYRIGHT © 2026 · IMCS · ALL RIGHTS RESERVED ·

Return to top

Caleb-Schlachter-for-web

Caleb R. Schlachter, Ph.D.

Principal Scientist
Caleb R. Schlachter, Ph.D., as the Principal Scientist at IMCS, leads and provides guidance for several research and development projects that involve proteins, including enzymes for glycan hydrolysis and glycan synthesis. He has co-authored multiple patents, posters, and peer-reviewed articles on β-glucuronidases and sulfatases.
Gray Amick for web

Gray D. Amick, Ph.D.

Director of Operations
Gray D. Amick, Ph.D., is the Director of Operations at IMCS with over 26 years of experience in forensic DNA analysis and toxicology. Prior to joining IMCS, he led forensic DNA testing for the Richland County Sheriff’s Department as technical leader and lab director. He has been court-qualified as an expert over 100 times and has authored and co-authored multiple posters and peer-reviewed articles.
Amanda M Headshot

Amanda C. McGee

Research Scientist
Amanda C. McGee is a Research Scientist at IMCS involved with enzyme characterizations, new analytical method developments, and advanced technical support. She joined IMCS with several years of experience in analytical testing for active pharmaceutical ingredients as per cGMP, USP and ICH guidelines. She has co-authored peer reviewed articles in the Journal of Analytical Toxicology and presented research at national and international conferences.
Andrew_Headshot

L. Andrew Lee, Ph.D.

Co-Founder and Chief Scientific Officer
L. Andrew Lee, Ph.D. co-founded IMCS and leads research and development efforts in enzyme engineering and automated micro-chromatography workflows. He directs new market efforts in glycan synthesis, supported by three NIH Fast-Track awards.

Get started with 2N1 below

"*" indicates required fields

Name*
Would you be interested in joining the 2N1 beta program?*
Which product are you interested in? (select all that apply)*
What are your current purification workflows? (select all that apply)*
Please select your automation platform(s) (select all that apply)*
How soon are you planning on evaluating 2N1?*
Consent*

DOWNLOAD OUR POSTERS

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Please select the posters you would like to download*
Name*
Please provide a valid email so we can send you the download link.
Location*
Automated Liquid Handling System
Contact preferences*
Consent*

Podcast Form

"*" indicates required fields

Name*
How would you like to connect?*
Please let us know what's on your mind. Have a question for us? Ask away.

Ready for a change? Get your FREE sample of IMCSzyme® RT today.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*
Consent*